• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CUV
Click for more information
1.36% $13.37

CLINUVEL PHARMACEUTICALS LIMITED

Market Cap $669.5M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Clinuvel Pharmaceuticals Limited is an Australia-based global specialty pharmaceutical... Clinuvel Pharmaceuticals Limited is an Australia-based global specialty pharmaceutical company. The Company is focused on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialized populations. Its lead therapy, SCENESSE (afamelanotide 16mg), is approved for commercial distribution in Europe, the USA, Israel, and Australia as the first systemic photoprotective drug for the prevention of phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP). The Company’s pharmaceuticals product development includes PRENUMBRA and NEURACTHEL. Its PhotoCosmetics product development includes CYACELLE and DNA Repair Assist and Melanogenesis. PRENUMBRA is a formulation of afamelanotide designed to provide a flexible dose in identified patient groups. NEURACTHEL is a novel formulation of the melanocortin adrenocorticotropic hormone (ACTH).More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CUV
THE CLINUVEL SHARE BUYBACK 		09:35 27 11K
09:35 Last post  LJSM Comments Created with Sketch.  27  Views Created with Sketch.  11K 
CUV
Ann: Ceasing to be a substantial holder 		23/08/24 0 232
23/08/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  232 
CUV
Ann: Becoming a substantial holder 		22/08/24 0 398
22/08/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  398 
CUV
Ann: Vitiligo and Operational Update 		22/08/24 20 5.7K
22/08/24 Last post  Silverchair Comments Created with Sketch.  20  Views Created with Sketch.  5.7K 
CUV
Surprise Surprise 		22/08/24 2 1.0K
22/08/24 Last post  bricklebar Comments Created with Sketch.  2  Views Created with Sketch.  1.0K 
CUV
Disc Medicine - Best comparison stock to Clinuvel
2 3
20/08/24 143 63K
20/08/24 Last post  Melon felon! Comments Created with Sketch.  143  Views Created with Sketch.  63K 
CUV
Ann: Annual Results Webinar 		20/08/24 14 4.0K
20/08/24 Last post  TheAnalyst007 Comments Created with Sketch.  14  Views Created with Sketch.  4.0K 
CUV
How to Remove a Director From a Company 		19/08/24 0 238
19/08/24 Last post  Melon felon! Comments Created with Sketch.  0  Views Created with Sketch.  238 

See All Discussions arrow Created with Sketch.

Timeline

Ceasing to be a substantial holder
23 Aug 18:36
 
Becoming a substantial holder
22 Aug 18:57
 
Vitiligo and Operational Update
21 Aug 09:12
 
Annual Results Webinar
19 Aug 09:35
 
Ceasing to be a substantial holder
15 Aug 17:29
 
Becoming a substantial holder
13 Aug 19:19
 
View More arrow Created with Sketch.

Featured News

RDN Raiden Resources hopeful it can start drilling Andover South, WA, as early as mid-October
right-arrow Created with Sketch.
SBW Shekel Brainweigh provides key business update ahead of final 2024 quarter
right-arrow Created with Sketch.
NEWS How institutional adoption is shaping the future of crypto
right-arrow Created with Sketch.
(20min delay)
Last
$13.37 		Change
0.180(1.36%) 		Mkt cap ! $669.5M
Open High Low Value Volume
$13.19 $13.59 $13.13 $1.181M 88.20K

Buyers (Bids)

No. Vol. Price($)
1 606 $13.31
 

Sellers (Offers)

Price($) Vol. No.
$13.51 282 1
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
Last
$13.37 		  Change
0.180 ( 1.23 %)
Open High Low Volume
$13.23 $13.61 $13.18 17074
Last updated 15.59pm 23/08/2024 ?
CUV (ASX) Chart

Top Stories

The Rising Tide: How institutional adoption is shaping the future of crypto

This year's institutional demand for Bitcoin supports stability & credibility for the asset class. We look at what's happened since crypto ETFs were approved in the US & what that means for Australian investors.
Week 34 Wrap: HotCopper's top watched; Oz banks cut saver interest; Kamala’s 28% corporate tax; AI’s back This week’s biggest story (in my view) for the Australian economy actually started late last week. Quietly, CBA cut its term deposit interest rates, prompting ANZ and NAB to do the same on Monday of this week.
IPH raises $100M to buy up Canadian IP firm Bereskin & Parr IPH Ltd has raised $100 million in an institutional placement to support the acquisition, while also launching a share purchase plan.
Noronex kicks off EM survey at Humpback, Namibia – part of South32's earn-in deal to access Kalahari Copper Belt Noronex Limited (ASX:NRX) has kicked off a gravity EM survey at the Damara project in Namibia – part of its earn-in deal with South32.
Raiden gears up for exploration in final quarter of 2024 Raiden Resources Ltd - which is exploration for a multiplicity of minerals in the Pilbara region of WA - is looking ahead to a busy schedule.

Featured News

RDN Raiden Resources hopeful it can start drilling Andover South, WA, as early as mid-October
right-arrow Created with Sketch.
SBW Shekel Brainweigh provides key business update ahead of final 2024 quarter
right-arrow Created with Sketch.
NEWS How institutional adoption is shaping the future of crypto
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.